Scynexis (SCYX) Interest & Investment Income (2016 - 2026)
Scynexis' (SCYX) quarterly Interest & Investment Income came in at $535000.0 in Q1 2026, down 31.06% YoY from $776000.0 in Q1 2025, and up 27.99% on a QoQ basis from $418000.0 in Q4 2025.
Scynexis (SCYX) Interest & Investment Income (2016 - 2026) Analysis & Trends
Scynexis (SCYX) has 11 years of Interest & Investment Income data on file, last reported at $535000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 31.06% year-over-year to $535000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 49.49% YoY) and the FY2025 annual result came in at $2.2 million, down 49.27% from the prior year.
- Interest & Investment Income advanced to $535000.0 in Q1 2026, from $418000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.4 million in Q4 2023 to a low of $13000.0 in Q1 2022.
- A 5-year average of $727000.0 and a median of $691000.0 in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 17175.0% — and 2025, when it plunged 55.49%.
- Tracing SCYX's Interest & Investment Income over 5 years: stood at $691000.0 in 2022, then soared by 97.4% to $1.4 million in 2023, then sank by 36.29% to $869000.0 in 2024, then slumped by 51.9% to $418000.0 in 2025, then grew by 27.99% to $535000.0 in 2026.
- The last three Interest & Investment Income figures came in at $535000.0 (Q1 2026), $418000.0 (Q4 2025), and $454000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Scynexis | 60.95 Mn | -53.74 Mn | - | 685,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 685,000.00 |
| Mar 31, 2026 | 535,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | 454,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 776,000.00 |
| Dec 31, 2024 | 869,000.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 737,000.00 |
| Mar 31, 2023 | 587,000.00 |
| Dec 31, 2022 | 691,000.00 |
| Sep 30, 2022 | 531,000.00 |
| Jun 30, 2022 | 181,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 8,000.00 |